Investor Relations
Announcements to Bursa
Stock Name / Code :
PHARMA - 7081
Category :
Bursa Announcements
Other Announcements
Year :
2024
2023
2022
2021
2020
Archives
Select date range :
News Type :
All
Special Announcement
Members Circular
Investor Alert Announcement
General Announcement / Listing Circular
Financial Summary Announcement
Entitlement Announcement
Changes in Boardroom / Chief Executive Officer
Trading of Rights Announcement
Changes in Substantial Shareholding
Changes in Substantial Shareholder’s Interest (29B)
Changes in Director’s Interest (S135)
Notice of Person Interest to be a Substantial Shareholder (29A)
Notice of Cessation of Substantial Shareholder (29C)
Change of Company Secretary
Notice of Shares Buy Back By A Company (28A)
Change of Address
Change of Registrar
Notice of Shares Buy Back By A Company (28B)
Notice of Shares Buy Back - Immediate Announcement
Financial Results Announcement
Notice of Resale/Cancellation of Treasury Share – Immediate Announcement
Changes in Audit Committee
Tuesday - 14 Mar 2023
OTHERS
Resignation of ZULKARNAIN MD EUSOPE As Chief Exec Officer
Tuesday - 28 Feb 2023
FINANCIAL CONDITION
PHARMA - New admission into PN17
PRACTICE NOTE 17 / GUIDANCE NOTE 3 (Amended)
Monday - 27 Feb 2023
PRACTICE NOTE 17 / GUIDANCE NOTE 3
Quarterly rpt on consolidated results for the financial period ended 31/12/2022
Thursday - 23 Feb 2023
Change in Nomination and Remuneration Committee (Amended)
Wednesday - 22 Feb 2023
Others of MOHAMED IQBAL ABDUL RAHMAN As Coo
Others of ZULKIFLI JAFAR As Others
Cessation of ZULKIFLI JAFAR As Others
Others of ZULKARNAIN MD EUSOPE As Chief Exec Officer
Cessation of ZULKARNAIN MD EUSOPE As Chief Exec Officer
Appointment of AHMAD SHAHREDZUAN BIN MOHD SHARIFF As Director
Change in Nomination and Remuneration Committee
«
1
2
3
4
5
6
7
8
9
10
»